Scinovex

Research article · 2025 · Full text

International Journal of Biology Sciences

Cardiovascular autonomic function and heart rate variability in athletes during overtraining syndrome

Yashwant SuryawanshiGokul BalasubramanianJanaki Phadke

Volume 7(5) · Pages 189–191 · DOI: 10.33545/26649926.2025.v7.i5c.727 ↗

Research areasHeart Rate Variability and Autonomic ControlSports Performance and TrainingCardiovascular and exercise physiology

↓ Read full-text PDF0 citations

Abstract

Author-written

Here is a surprising fact: elite athletes who train the hardest sometimes perform the worst - a paradox known as overtraining syndrome (OTS). This research tracked heart rate variability (HRV) and autonomic cardiovascular markers in 32 competitive middle-distance runners over a 14-week training cycle that included a deliberate overreaching phase. Athletes were monitored at the Rajputana Institute of Molecular Biology, Jaipur, from January to May 2023. Resting HRV was recorded weekly using 5-minute supine ECG (Polar H10), and time-domain (RMSSD, SDNN) and frequency-domain (LF/HF ratio) parameters were calculated. Baroreflex sensitivity was assessed fortnightly by the sequence method. Eight athletes (25%) developed functional overreaching criteria by week 10 (performance decline >5%, persistent fatigue, mood disturbance). In these athletes, RMSSD dropped from 42.3±4.8 ms at baseline to 18.6±3.7 ms during overreaching (p < 0.001), while LF/HF ratio doubled from 1.8 to 3.4, indicating a sympathetic shift. Baroreflex sensitivity fell from 12.4 to 7.1 ms/mmHg. Athletes who didn't develop OTS showed stable HRV throughout. ROC analysis identified RMSSD < 25 ms as the best single predictor of OTS onset (AUC 0.91, sensitivity 87.5%, specificity 83.3%). These findings position HRV monitoring as a practical early-warning tool for overtraining in competitive runners.

Summary

Source-checked

Plain-language reading of the full paper, prepared with AI and checked against the text. Each point links to the authors' own words.

  1. Why it matters

    • Overtraining syndrome (OTS) occurs when athletes exceed their recovery capacity, leading to long-term performance decline, fatigue, and mood disturbances. View evidence ↗

      Why it matters

      Overtraining syndrome (OTS) occurs when athletes exceed their recovery capacity, leading to long-term performance decline, fatigue, and mood disturbances.

      In the paper's own words

      “Overtraining syndrome sits at the extreme end of this curve: athletes who chronically exceed their recovery capacity develop persistent fatigue, mood disturbance, immunosuppression, and paradoxical performance decline that can last months”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
    • Athletes who are well-trained generally exhibit high heart rate variability (HRV), low resting heart rates, and strong baroreflex sensitivity, indicating enhanced parasympathetic tone. View evidence ↗

      Why it matters

      Athletes who are well-trained generally exhibit high heart rate variability (HRV), low resting heart rates, and strong baroreflex sensitivity, indicating enhanced parasympathetic tone.

      In the paper's own words

      “Well-trained athletes typically show enhanced parasympathetic tone - reflected in high HRV, low resting heart rate, and strong baroreflex sensitivity”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
    • Excessive training loads can shift the autonomic nervous system from parasympathetic dominance to sympathetic overactivity, resulting in decreased HRV and weakened baroreflex control. View evidence ↗

      Why it matters

      Excessive training loads can shift the autonomic nervous system from parasympathetic dominance to sympathetic overactivity, resulting in decreased HRV and weakened baroreflex control.

      In the paper's own words

      “When training load overwhelms recovery, this parasympathetic dominance gives way to sympathetic overactivity: heart rate rises, HRV drops, and baroreflex control weakens”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
  2. The question

    • The study aimed to identify a specific heart rate variability (HRV) threshold that could best predict the onset of overtraining syndrome in competitive runners. View evidence ↗

      The question

      The study aimed to identify a specific heart rate variability (HRV) threshold that could best predict the onset of overtraining syndrome in competitive runners.

      In the paper's own words

      “This research prospectively tracked autonomic cardiovascular function in competitive runners through a structured training cycle designed to push some athletes into functional overreaching, aiming to identify the HRV threshold that best predicts OTS onset.”

      Page 1

      Found in: Introduction

      Read it in the full textOpen PDF at page 1 ↗
  3. What they did

    • Participants followed a 14-week training protocol that included a peak training phase (weeks 7-9) where volume was increased by 30% above baseline. View evidence ↗

      What they did

      Participants followed a 14-week training protocol that included a peak training phase (weeks 7-9) where volume was increased by 30% above baseline.

      In the paper's own words

      “The 14-week protocol comprised: baseline (weeks 1-2), progressive build (weeks 3-6), peak training (weeks 7-9, volume increased 30% above baseline), maintained overload (weeks 10-11), and recovery taper (weeks 12-14).”

      Page 2

      Found in: Methods

      Read it in the full textOpen PDF at page 2 ↗
    • Researchers recorded weekly 5-minute supine resting ECGs to calculate time-domain (e.g., RMSSD, SDNN) and frequency-domain (e.g., LF/HF ratio) HRV parameters. View evidence ↗

      What they did

      Researchers recorded weekly 5-minute supine resting ECGs to calculate time-domain (e.g., RMSSD, SDNN) and frequency-domain (e.g., LF/HF ratio) HRV parameters.

      In the paper's own words

      “Weekly 5-minute supine resting ECG recordings were taken every Monday morning before training. Time-domain (RMSSD, SDNN, pNN50) and frequency-domain (LF power, HF power, LF/HF ratio) HRV parameters were computed in Kubios HRV Premium.”

      Page 2

      Found in: Methods

      Read it in the full textOpen PDF at page 2 ↗
  4. What they found

    • Athletes who developed OTS experienced a significant drop in RMSSD from 42.3±4.8 ms at baseline to 18.6±3.7 ms during overreaching. View evidence ↗

      What they found

      Athletes who developed OTS experienced a significant drop in RMSSD from 42.3±4.8 ms at baseline to 18.6±3.7 ms during overreaching.

      In the paper's own words

      “In these athletes, RMSSD dropped from 42.3±4.8 ms at baseline to 18.6±3.7 ms during overreaching (p < 0.001)”

      Page 1

      “RMSSD (ms) | 42.3±4.8 | 18.6±3.7 | 44.1±5.2 | 38.4±4.6”

      Page 2

      Found in: Table 1

      Read it in the full textOpen PDF at page 1 ↗
    • The LF/HF ratio in OTS athletes increased from 1.8 to 3.4, signaling a shift toward sympathetic nervous system activity. View evidence ↗

      What they found

      The LF/HF ratio in OTS athletes increased from 1.8 to 3.4, signaling a shift toward sympathetic nervous system activity.

      In the paper's own words

      “while LF/HF ratio doubled from 1.8 to 3.4, indicating a sympathetic shift.”

      Page 1

      “LF/HF ratio | 1.8±0.4 | 3.4±0.6 | 1.7±0.3 | 2.0±0.4”

      Page 2

      Found in: Table 1

      Read it in the full textOpen PDF at page 1 ↗
    • Baroreflex sensitivity in the OTS group decreased from 12.4 to 7.1 ms/mmHg. View evidence ↗

      What they found

      Baroreflex sensitivity in the OTS group decreased from 12.4 to 7.1 ms/mmHg.

      In the paper's own words

      “Baroreflex sensitivity fell from 12.4 to 7.1 ms/mmHg.”

      Page 1

      “BRS (ms/mmHg) | 12.4±2.1 | 7.1±1.8 | 13.1±2.3 | 11.8±2.0”

      Page 2

      Found in: Table 1

      Read it in the full textOpen PDF at page 1 ↗
    • An RMSSD value below 25 ms was identified as the most effective single predictor for the onset of OTS, with an AUC of 0.91. View evidence ↗

      What they found

      An RMSSD value below 25 ms was identified as the most effective single predictor for the onset of OTS, with an AUC of 0.91.

      In the paper's own words

      “ROC analysis identified RMSSD < 25 ms as the best single predictor of OTS onset (AUC 0.91, sensitivity 87.5%, specificity 83.3%).”

      Page 1

      “RMSSD < 25 ms at any single weekly measurement had an AUC of 0.91 for predicting OTS.”

      Page 2

      Found in: Results

      Read it in the full textOpen PDF at page 1 ↗
    • HRV declines began during the peak training phase (weeks 7-9), providing a predictive lead time of approximately two weeks before performance decline was measured at week 11. View evidence ↗

      What they found

      HRV declines began during the peak training phase (weeks 7-9), providing a predictive lead time of approximately two weeks before performance decline was measured at week 11.

      In the paper's own words

      “The fact that this decline began during the peak training phase (weeks 7-9) before performance decline was measurable at week 11 gives HRV a roughly 2-week lead time as a predictive marker.”

      Page 3

      Found in: Discussion

      Read it in the full textOpen PDF at page 3 ↗
  5. What it means

    • The authors recommend an immediate reduction in training load if an athlete's RMSSD drops below 25 ms or declines by more than 40% from their personal baseline. View evidence ↗

      What it means

      The authors recommend an immediate reduction in training load if an athlete's RMSSD drops below 25 ms or declines by more than 40% from their personal baseline.

      In the paper's own words

      “An RMSSD drop below 25 ms - or alternatively, a >40% decline from personal baseline - should trigger an immediate training load reduction”

      Page 3

      Found in: Discussion

      Read it in the full textOpen PDF at page 3 ↗
    • The authors conclude that integrating HRV tracking into routine monitoring is a practical, non-invasive way to prevent overtraining in athletes. View evidence ↗

      What it means

      The authors conclude that integrating HRV tracking into routine monitoring is a practical, non-invasive way to prevent overtraining in athletes.

      In the paper's own words

      “These data support integrating HRV tracking into routine athlete monitoring programs as a practical, non-invasive tool for preventing overtraining”

      Page 3

      Found in: Conclusion

      Read it in the full textOpen PDF at page 3 ↗

Visual summary

3 visuals

Illustrations explain the paper; charts are replotted from the paper's own table values.

AI-generated illustration
AI-generated conceptual illustration (human heart and autonomic nervous system). It explains the idea and does not show study data.↗ Enlarge
Autonomic Shift in Overtraining
AI-generated conceptual illustration (human heart and autonomic nervous system). It explains the idea and does not show study data.

AI-generated conceptual illustration (human heart and autonomic nervous system). It explains the idea and does not show study data.

Open full-size image ↗

Autonomic Shift in Overtraining

AI-generated conceptual illustration (human heart and autonomic nervous system). It explains the idea and does not show study data.

View source evidence ↗
Replotted from source data
Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.↗ Enlarge
RMSSD (ms): OTS baseline vs OTS wk 10 vs Non-OTS base vs Non-OTS wk 10
Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

Open full-size image ↗

RMSSD (ms): OTS baseline vs OTS wk 10 vs Non-OTS base vs Non-OTS wk 10

Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

View source evidence ↗
Replotted from source data
Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.↗ Enlarge
LF/HF ratio: OTS baseline vs OTS wk 10 vs Non-OTS base vs Non-OTS wk 10
Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

Open full-size image ↗

LF/HF ratio: OTS baseline vs OTS wk 10 vs Non-OTS base vs Non-OTS wk 10

Replotted from Table 1 (page 2) of the original paper. Every bar is the paper's own table value.

View source evidence ↗

Figures & tables

From the original paper
HRV and autonomic parameters in athletes whoTable 1Page 2RMSSD and SDNN values across five training phases in athletes who developed overtraining syndromeFigure 1Page 2Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndromeFigure 2Page 2
FULL TEXT Original article · reflowed for reading

Introduction

A surprising fact about athletic performance is that the relationship between training load and fitness isn't linear - past a certain point, more training produces less performance, and eventually negative returns [1]. Overtraining syndrome sits at the extreme end of this curve: athletes who chronically exceed their recovery capacity develop persistent fatigue, mood disturbance, immunosuppression, and paradoxical performance decline that can last months [2]. The autonomic nervous system (ANS) mediates many of the physiological responses to training stress. Well-trained athletes typically show enhanced parasympathetic tone - reflected in high HRV, low resting heart rate, and strong baroreflex sensitivity [3].

When training load overwhelms recovery, this parasympathetic dominance gives way to sympathetic overactivity: heart rate rises, HRV drops, and baroreflex control weakens [4]. But whether HRV changes precede the clinical symptoms of OTS by enough time to serve as early-warning markers remains debated [5]. This research prospectively tracked autonomic cardiovascular function in competitive runners through a structured training cycle designed to push some athletes into functional overreaching, aiming to identify the HRV threshold that best predicts OTS onset.

Material And Methods

Material Thirty-two competitive middle-distance runners (18 male, 14 female; age 22.4±3.1 years; VO2max 58.7±4.3 ml/kg/min) were recruited from athletics clubs in Jaipur, Rajasthan. Inclusion criteria: ≥3 years of competitive training, no cardiovascular disease, no beta- blocker or stimulant use. HRV was recorded using Polar H10 chest-strap monitors paired with the Kubios HRV app. Baroreflex assessment used continuous finger blood pressure recording (Finapres NOVA) with simultaneous ECG.

Ethics approval: Rajputana Institute Human Research Ethics Committee (Protocol RIMB-HREC-2022-028, December 2022). https://www.biologyjournal.net

Results

Table 1: HRV and autonomic parameters in athletes who developed OTS (n = 8) vs those who did not (n = 24) at baseline and week 10 (mean ± SD) Parameter OTS baseline OTS wk 10 Non-OTS base Non-OTS wk 10 RMSSD (ms) 42.3±4.8 18.6±3.7 44.1±5.2 38.4±4.6 SDNN (ms) 48.7±5.3 22.4±4.1 50.2±5.8 43.7±5.1 LF/HF ratio 1.8±0.4 3.4±0.6 1.7±0.3 2.0±0.4 BRS (ms/mmHg) 12.4±2.1 7.1±1.8 13.1±2.3 11.8±2.0 Rest HR (bpm) 54.2±4.1 68.7±5.3 53.8±3.9 56.4±4.2 OTS athletes showed dramatic HRV declines by week 10 while non-OTS athletes maintained near-baseline values (Table 1). The interaction between group and time was significant for all parameters (p < 0.001). RMSSD < 25 ms at any single weekly measurement had an AUC of 0.91 for predicting OTS.

Table 1. HRV and autonomic parameters in athletes who
ParameterOTS baselineOTS wk 10Non-OTS baseNon-OTS wk 10
RMSSD (ms)42.3±4.818.6±3.744.1±5.238.4±4.6
SDNN (ms)48.7±5.322.4±4.150.2±5.843.7±5.1
LF/HF ratio1.8±0.43.4±0.61.7±0.32.0±0.4
BRS (ms/mmHg)12.4±2.17.1±1.813.1±2.311.8±2.0
Rest HR (bpm)54.2±4.168.7±5.353.8±3.956.4±4.2

Table text extracted from the original PDF; superscript letters are shown inline. The original table image is below.

View original table image
HRV and autonomic parameters in athletes who↗ Enlarge
Table 1
HRV and autonomic parameters in athletes who

HRV and autonomic parameters in athletes who

Open full-size image ↗
Original paper tableSource PDF · page 2 ↗

Methods

The 14-week protocol comprised: baseline (weeks 1-2), progressive build (weeks 3-6), peak training (weeks 7-9, volume increased 30% above baseline), maintained overload (weeks 10-11), and recovery taper (weeks 12-14). Weekly 5-minute supine resting ECG recordings were taken every Monday morning before training. Time-domain (RMSSD, SDNN, pNN50) and frequency-domain (LF power, HF power, LF/HF ratio) HRV parameters were computed in Kubios HRV Premium. Resting heart rate, blood pressure, and mood (Profile of Mood States questionnaire) were recorded weekly.

Performance was assessed by 3000m time trial at weeks 2, 6, 9, 11, and 14. OTS was defined as: >5% decline in time-trial performance at week 11 vs week 6, plus persistent fatigue and mood disturbance for >2 weeks [6]. Baroreflex sensitivity was measured fortnightly using the spontaneous sequence method. ROC curves for OTS prediction were constructed for each HRV parameter.

Two- way mixed ANOVA (group × time) compared OTS and non-OTS athletes. Fig 1: RMSSD and SDNN values across five training phases in athletes who developed overtraining syndrome Fig 2: Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndrome https://www.biologyjournal.net 12. Schmitt L, Regnard J, Millet GP. Monitoring fatigue status with HRV measures in elite athletes.

Figure 2. Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndrome
Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndrome↗ Enlarge
Figure 2
Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndrome

Comparison of normalized autonomic cardiovascular parameters between normal training response and overtraining syndrome

Open full-size image ↗
Original paper figureSource PDF · page 2 ↗
Figure 1. RMSSD and SDNN values across five training phases in athletes who developed overtraining syndrome
RMSSD and SDNN values across five training phases in athletes who developed overtraining syndrome↗ Enlarge
Figure 1
RMSSD and SDNN values across five training phases in athletes who developed overtraining syndrome

RMSSD and SDNN values across five training phases in athletes who developed overtraining syndrome

Open full-size image ↗
Original paper figureSource PDF · page 2 ↗

Frontiers in Physiology. 2015;6:71. 13. Le Meur Y, Pichon A, Schaal K, Bhagat C, Bhagat D, Hauswirth C. Evidence of parasympathetic hyperactivity in functionally overreached athletes. Medicine and Science in Sports and Exercise. 2013;45(11):2061-2071. 14.

Bellenger CR, Fuller JT, Thomson RL, Davison K, Robertson EY, Buckley JD. Monitoring athletic training status through autonomic heart rate regulation: a systematic review and meta-analysis. Sports Medicine. 2016;46(10):1461-1486.

Discussion

The 56% drop in RMSSD during overreaching - from 42.3 to 18.6 ms - is among the largest reported in prospective OTS monitoring research and exceeded the threshold that Plews and colleagues proposed for clinically meaningful HRV suppression [7, 8]. The fact that this decline began during the peak training phase (weeks 7-9) before performance decline was measurable at week 11 gives HRV a roughly 2-week lead time as a predictive marker. The practical implication is straightforward: coaches who monitor weekly morning RMSSD can identify athletes heading toward OTS before the damage is done. An RMSSD drop below 25 ms - or alternatively, a >40% decline from personal baseline - should trigger an immediate training load reduction [9, 10].

Conclusion

Weekly HRV monitoring identified athletes developing overtraining syndrome approximately two weeks before clinical symptoms became apparent. RMSSD was the most sensitive single marker (AUC 0.91), and a threshold of 25 ms distinguished OTS from normal training adaptation. These data support integrating HRV tracking into routine athlete monitoring programs as a practical, non-invasive tool for preventing overtraining [11, 12, 13, 14].

References

11 in the original paper
  1. Meeusen R, Duclos M, Foster C, Fry A, Gleeson M, Nieman D, Bhagat C, Bhagat D, Urhausen A. Prevention, diagnosis, and treatment of the overtraining syndrome. Medicine and Science in Sports and Exercise. 2013;45(1):186-205.
  2. Kreher JB, Schwartz JB. Overtraining syndrome: a practical guide. Sports Health. 2012;4(2):128-138.
  3. Aubert AE, Seps B, Beckers F. Heart rate variability in athletes. Sports Medicine. 2003;33(12):889-919.
  4. Borresen J, Lambert MI. Autonomic control of heart rate during and after exercise. Sports Medicine. 2008;38(8):633-646.
  5. Plews DJ, Laursen PB, Stanley J, Kilding AE, Buchheit M. Training adaptation and heart rate variability in elite endurance athletes: opening the door to effective monitoring. Sports Medicine. 2013;43(9):773-781.
  6. Halson SL, Jeukendrup AE. Does overtraining exist? An analysis of overreaching and overtraining research. Sports Medicine. 2004;34(14):967-981.
  7. Plews DJ, Laursen PB, Kilding AE, Buchheit M. Heart- rate variability and training-intensity distribution in elite rowers. International Journal of Sports Physiology and Performance. 2014;9(6):1026-1032.
  8. Buchheit M. Monitoring training status with HR measures: do all roads lead to Rome? Frontiers in Physiology. 2014;5:73.
  9. Stanley J, Peake JM, Buchheit M. Cardiac parasympathetic reactivation following exercise. Sports Medicine. 2013;43(12):1259-1277.
  10. Kiviniemi AM, Hautala AJ, Kinnunen H, Tulppo MP. Endurance training guided individually by daily heart rate variability measurements. European Journal of Applied Physiology. 2007;101(6):743-751.
  11. Task Force. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043-1065.